has initiated coverage of 7 new biotechs, with AMBS on top of his list. He is getting overwhelmed by the flood of AMBS pipeline, data and history. There will be other analysts covering AMBS soon. It is only a matter of time before the market wakes up. The market is nothing but a fancy word for a collection of investors. Remember that some of the heavyweight biotechs with some of the biggest and reputed analysts backing them up, have nose-dived. This opens up investment opportunities in newer, unseen, under the radar, smaller biotechs with promise. And guess what, nothing lights up the OTC world as AMBS. I have repeatedly said, be proactive and outsmart the market. My 6-12 month target is $15. I only care for the science and AMBS has it in its favor.
Hey Bigband: Care to provide hypothetical details on how AMBS could get to $15 in 6 to 12 months? With 700 million outstanding shares, that would be a market cap of 10 Billion dollars. Why don't you give us a break down? This isn't another one of your lame RS pranks is it? Don't you ever get tired raising false expectations in naïve people on the mb and then shorting them and taking their money away? That's kind of an ugly way of making a living, even if you are "interested in the science." LOL, what a joker! Only in America. Hypothetically prove me wrong. Give us some catalysts and numbers that get us up to 10 billion. You won't because you can't.
risk...don't attack a shareholder...everyone that is long is speculative, that being said, I take speculation with a grain of salt. It's not that I am against speculation, we wouldn't be here otherwise, in fact there would be ZERO interest if it wasn't for speculation! I like his enthusiasm so maybe some slack would be warranted....In the end, we all want AMBS to succeed, and succeed it will from my vantage point anyways...
Sentiment: Strong Buy